<DOC>
	<DOCNO>NCT02299843</DOCNO>
	<brief_summary>Currently，the `` ALPPS '' ( associate liver partition portal vein ligation stag hepatectomy ) procedure enable rapid growth future liver remnant extend surgical indication patient mid-advanced stage hepatocellular carcinoma become research hot spot . However , procedure high morbidity mortality rate.Using radio-frequency ablation instead in-situ split liver avoid form coagulation band stage I reduce incidence complications（bile leakage , abdominal infection , hemorrhage e.t . ) The investigator name technique Radio-frequency Assisted Liver Partition Portal vein ligation stag hepatectomy （RALPPS）.Investigators hypothesize RALPPS might result low morbidity mortality rate ALPPS treatment hepatocellular carcinoma . This Prospective Randomized Controlled Trial Safety Efficacy radio-frequency assist liver partition portal vein ligation stag hepatectomy hepatocellular carcinoma .</brief_summary>
	<brief_title>RALPPS Venus ALPPS Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>An insufficient future liver remnant ( FLR＜30 % normal hepatic function FLR＜40 % hepatic cirrhosis chemotherapy） Liver function ChildPugh Class A B. Liver Reserve Function：ICGR15≤10％ No evidence coagulopathy : platelet count &gt; 50 × 109/L prolonged prothrombin time &lt; 5 second . Patients meet inclusion criterion decline participate . Patients severe portal hypertension , history esophageal variceal hemorrhage , severe hypersplenism syndrome , refractory ascites . Main portal vein、inferior vena cava、common hepatic duct hepatic vein tumor thrombus . Extrahepatic lymph node metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>RFA</keyword>
	<keyword>ALPPS</keyword>
	<keyword>hepatectomy</keyword>
	<keyword>morbidity mortality</keyword>
</DOC>